About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
British Journal of Pharmacology
›
Top Articles
British Journal of Pharmacology
Pharmacology
8.6
(top 1%)
Impact Factor
9.3
(top 1%)
extended IF
252
(top 1%)
H-Index
9.9K
authors
24.5K
papers
896.5K
citations
9.8K
citing journals
193.5K
citing authors
Most Cited Articles of British Journal of Pharmacology
Title
Year
Citations
Animal research: reporting in vivo experiments: the ARRIVE guidelines
2010
2.7K
Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?
2004
1.5K
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
1990
1.5K
Stimulus-secretion coupling: the concept and clues from chromaffin and other cells
1968
1.2K
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin
2008
1.1K
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate
1983
1.1K
The orphan receptor GPR55 is a novel cannabinoid receptor
2007
1.1K
Principles of early drug discovery
2011
1.1K
The role of inflammation in CNS injury and disease
2006
901
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide
1987
898
Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release
1977
880
Therapeutic antibodies: successes, limitations and hopes for the future
2009
879
Endothelial dysfunction in diabetes
2000
815
Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain
1970
813
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
2011
793
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
2011
755
Microglial M1/M2 polarization and metabolic states
2016
751
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
2001
747
Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors
1998
727
A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation
1989
712
Guide to Receptors and Channels (GRAC), 5th edition
2011
702
The use of animal models in diabetes research
2012
697
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
2009
684
L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro
1990
662
Role of transmitter uptake mechanisms in synaptic neurotransmission
1971
657
previous
2004
2005
2006
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.